Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins to Acquire DNA Diagnostics Center

NEW YORK — DNA Diagnostics Center, a provider of at-home DNA testing products, said on Monday that it will be acquired by Eurofins for an undisclosed sum.

The transaction is expected to close in the third quarter. DDC is being sold by private equity firm GHO Capital, which acquired it in 2015 for about $118 million.

DDC's portfolio includes tests for paternity, fertility, COVID-19, ancestry, and wellness. The company, which has around 240 employees and expects 2021 revenues of over $55 million, said it will continue to operate out of its Fairfield, Ohio-based facility following the acquisition.

"DDC is well placed to accelerate further, and we look forward to partnering with Eurofins to bring more products to our consumer and distributor channels," Scott Cramer, DDC's president and CEO, said in a statement.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.